Time to completion of conditions required by Health Canada after approving new drugs: A cohort study
Joel Lexchin
Health Policy, 2025, vol. 155, issue C
Abstract:
To ensure that promising drugs for serious illnesses reach Canadians in a timely manner, Health Canada can approve them conditionally provided companies commit to conducting confirmatory studies to verify the benefits.
Keywords: Conditional approval; Fulfillment; Health canada; New drug; New indication; Orphan status; Qualifying notice (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851025000703
Full text for ScienceDirect subscribers only
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:155:y:2025:i:c:s0168851025000703
DOI: 10.1016/j.healthpol.2025.105314
Access Statistics for this article
Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput
More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().